These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9439398)

  • 1. The role of vimentin expression in predicting the long-term outcome of patients with localized renal cell carcinoma.
    Sabo E; Miselevich I; Bejar J; Segenreich M; Wald M; Moskovitz B; Nativ O
    Br J Urol; 1997 Dec; 80(6):864-8. PubMed ID: 9439398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma.
    Nativ O; Sabo E; Bejar J; Halachmi S; Moskovitz B; Miselevich I
    Br J Urol; 1996 Jul; 78(1):33-8. PubMed ID: 8795397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
    Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
    Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of vimentin positivity in formalin-fixed renal cell carcinomas.
    Donhuijsen K; Schulz S
    Pathol Res Pract; 1989 Mar; 184(3):287-91. PubMed ID: 2748452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
    Harada K; Miyake H; Kusuda Y; Fujisawa M
    BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma.
    Hatiboglu G; Pritsch M; Macher-Goeppinger S; Zöller M; Huber J; Haferkamp A; Pahernik S; Wagener N; Hohenfellner M
    Scand J Urol; 2013 Aug; 47(4):311-22. PubMed ID: 23140095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.
    Ingels A; Hew M; Algaba F; de Boer OJ; van Moorselaar RJ; Horenblas S; Zondervan P; de la Rosette JJ; Pilar Laguna Pes M
    World J Urol; 2017 Jan; 35(1):81-87. PubMed ID: 27207480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Utility of EMA, Vimentin and CD117 Immunohistochemical Markers in Subtyping Renal Cell Carcinoma in a Nigerian Tertiary Hospital: A 10-year Retrospective Study.
    Nwadiokwu JI; Adegoke OO; Ajani MA; Okolo CA; Awosusi BL; Okebalama VC
    West Afr J Med; 2023 Oct; 40(10):1035-1040. PubMed ID: 37906498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.
    Bamias A; Chorti M; Deliveliotis C; Trakas N; Skolarikos A; Protogerou B; Legaki S; Tsakalou G; Tamvakis N; Dimopoulos MA
    Urology; 2003 Aug; 62(2):368-73. PubMed ID: 12893366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma.
    Pichler M; Hutterer GC; Chromecki TF; Pummer K; Mannweiler S; Zigeuner R
    Histopathology; 2013 Jan; 62(2):219-28. PubMed ID: 22957986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
    Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
    Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
    BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
    J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma.
    Haferkamp A; Bedke J; Vetter C; Pritsch M; Wagener N; Buse S; Crnkovic-Mertens I; Hoppe-Seyler K; Macher-Goeppinger S; Hoppe-Seyler F; Autschbach F; Hohenfellner M
    BJU Int; 2008 Dec; 102(11):1700-6. PubMed ID: 18990137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.